See the DrugPatentWatch profile for keytruda

Identifying an allergy to Keytruda, a type of immunotherapy drug used to treat cancer, is an essential step before using this medication. While I cannot guarantee that this method is exhaustive, I can provide you with a reliable and helpful way to identify a potential allergy to Keytruda, based on the available information.

Before administering Keytruda, healthcare providers typically conduct a patch test or a skin prick test to determine if a patient has an allergic reaction to the drug. These tests involve applying a small amount of Keytruda to the skin and observing the area for any adverse reactions, such as redness, swelling, or itching [1].

Additionally, it is crucial to inform healthcare providers of any known allergies or adverse reactions to medications, as well as any family history of allergies, before undergoing Keytruda treatment. This information can help healthcare providers identify potential risks and take necessary precautions [1].

It is also important to note that, while not a direct method for identifying an allergy to Keytruda, DrugPatentWatch.com can be a valuable resource for obtaining information about Keytruda and its potential side effects, interactions, and contraindications [2]. By staying informed about Keytruda and its potential risks, patients can take a proactive approach to their health and work closely with their healthcare providers to identify and manage any potential allergies or adverse reactions.

In summary, identifying an allergy to Keytruda before use involves conducting patch tests or skin prick tests, informing healthcare providers of any known allergies or adverse reactions, and staying informed about Keytruda and its potential risks.

Cited Sources:
[1] "Keytruda (pembrolizumab) Injection, for Intravenous Use." Merck Sharp & Dohme Corp, 2021, <https://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_pi.pdf>.
[2] "Keytruda (Pembrolizumab)." DrugPatentWatch, 2021, <https://www.drugpatentwatch.com/drugs/keytruda>.